-
公开(公告)号:EP0756003A4
公开(公告)日:1997-11-12
申请号:EP95906540
申请日:1995-01-30
发明人: TAKAZAWA YOSHIHARU , ARAI TAKAMI , MOTOKI MASAMICHI , NAGURA KENJI , YOKOYAMA SEIICHI , MIYATSU YOSHINOBU , MIZOKAMI HIROSHI
CPC分类号: C12N9/6464 , C12N5/0018 , C12N2501/999 , C12Y304/21069
摘要: A method of culturing animal cells in a medium containing a compound represented by general formula (I), whereby the growth of animal cells can be accelerated at a good reproducibility, wherein R represents COOM or CHO; M represents hydrogen, alkali metal or C1-C3 alkyl; and n represents an integer of 1 to 3.
摘要翻译: 在含有通式(I)所示化合物的培养基中培养动物细胞的方法,由此可以以良好的再现性加速动物细胞的生长,其中R代表COOM或CHO; M代表氢,碱金属或C 1 -C 3烷基; n表示1〜3的整数。
-
公开(公告)号:EP1043310A4
公开(公告)日:2001-03-21
申请号:EP98954747
申请日:1998-11-19
申请人: TEIJIN LTD
发明人: HARA TAKAYUKI , NAKADA TOMOHISA , TAKANO YASUNOBU , SUGIURA SATOSHI , TSUTSUMI TAKAHARU , TAKAZAWA YOSHIHARU , TAKARADA REIKO
IPC分类号: A61K31/155 , A61K31/195 , A61K31/24 , A61K31/275 , A61K31/40 , A61K31/415 , A61K31/495 , A61K31/695 , A61P7/02 , C07C251/18 , C07C257/18 , C07D207/08 , C07D207/09 , C07D207/16 , C07D211/22 , C07D211/26 , C07D211/28 , C07D211/40 , C07D211/46 , C07D211/62 , C07D295/08 , C07F7/18
CPC分类号: C07D207/08 , C07C251/18 , C07C257/18 , C07C2601/14 , C07D207/09 , C07D207/16 , C07D211/22 , C07D211/26 , C07D211/28 , C07D211/40 , C07D211/62
摘要: Biphenylamidine derivatives represented by general formula (1) or pharmaceutically acceptable salts thereof, both being novel compounds functioning as clinically applicable Fxa inhibitors.
-
公开(公告)号:EP1043311A4
公开(公告)日:2001-01-24
申请号:EP98954748
申请日:1998-11-19
申请人: TEIJIN LTD
发明人: TAKANO YASUNOBU , NAKADA TOMOHISA , HARA TAKAYUKI , SUGIURA SATOSHI , TSUTSUMI TAKAHARU , TAKARADA REIKO , TAKAZAWA YOSHIHARU
IPC分类号: C07C257/18 , C07D209/08 , C07D209/44 , C07D213/64 , C07D213/65 , C07D213/68 , C07D213/73 , A61K31/155 , A61K31/40 , A61K31/44 , C07D209/14 , C07D213/55
CPC分类号: C07D213/64 , C07C257/18 , C07C2602/46 , C07D209/08 , C07D209/44 , C07D213/65 , C07D213/68 , C07D213/73
摘要: Biphenylamidine derivatives represented by general formula (1) or pharmaceutically acceptable salts thereof, both being novel compounds functioning as clinically applicable Fxa inhibitors.
摘要翻译: 由通式(1)表示的联苯基脒衍生物或其药学上可接受的盐,两者都是用作临床适用的Fxa抑制剂的新化合物。
-
-